top-tier player healthcar industri given
updat forecast estim jun
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jun
estim jun
price data jul
rate updat jul
currenc amount express
valuat growth profit
methodolog valu compani
sought strategi expand beyond legaci
retail pharmaci oper becom healthcar servic
compani firm posit major player within
 healthcar ecosystem build top-tier
pharmaci benefit manag one largest pharmaci
retail firm recent announc seek acquir aetna
move vertic expand oper health insur
success close deal execut
ambiti strategi would transform one
power player within healthcar space
view strateg move posit oper
standpoint believ new cvs/aetna healthcar
servic behemoth infrastructur sell insur
manag member everi aspect treatment
regimen howev concern overpay aetna
materi amount given believ pay almost doubl
believ aetna worth stand-alone basi mean
aetna signific pressur execut
integr minim issu given complex larg
natur entiti believ materi risk sharehold
valu may impair
addit new cvs/aetna structur brand-new
busi model uncertainti surround prospect
prevent us rate new firm wide econom moat
howev believ major opportun
combin entiti reduc cost treat insur member
like firm eventu earn
cost capit extend period accordingli believ
new cvs/aetna least possess narrow econom moat
owner largest network retail pharmaci
 asset play key role new entiti new
firm eventu turn retail locat healthcare-hub
member obtain plethora healthcar servic
product hub allow new firm drive
healthcar cost entir membership book low
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
vertic integr one largest retail pharmaci
chain unit state one largest pharmaci benefit
manag combin make one premier healthcar firm
 compani process approxim billion prescript
per year oper retail pharmaci across
firm seek acquir aetna extend
vertic reach creat integr healthcar player
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
valuat growth profit jun
lower fair valu estim
incorpor tweak
combin cvs/aetna model shore cost
forecast combin entiti believ synergi
new healthcar hub strategi fulli ramp
end explicit forecast earliest
addit chang probabl deal close
grown confid
vertic merger receiv justic depart approv
given recent court rule also tweak capit
structur assumpt assum firm use
greater portion debt capit believ firm
massiv overpay acquisit aetna
high probabl sharehold valu
destruct result price pay doubl
believ aetna worth stand-alone basi
cumul effect chang lead
reduct fair valu estim
oper standpoint believ
slight neg effect near-term oper margin
result revenu mix shift loss certain client
contract within pbm segment long-term return
invest capit remain highli posit given
confluenc enhanc capit effici increas
pharmaceut purchas volum posit synergi
firm gain wide-moat pbm segment
pbm segment forecast adjust claim increas
five-year compound annual growth rate
oper profit per adjust claim increas
five-year compound-annual-growth-rate explicit forecast built
assumpt client growth increas claim volum
per client retail pharmaci segment forecast
revenu increas revenu compound-annual-growth-rate oper
margin averag includ increas cost
run new healthcar
addit model metric factor
aetna specif solid per-memb growth
decreas member medic cost firm healthcar
hub strategi help lower member treatment expens
addit believ materi leverag
central cost administr underwrit
central cost scale across entir organ
includ aetna acquisit believ revenu
grow compound-annual-growth-rate oper incom grow
compound-annual-growth-rate period
scenario analysi take consider sever
variabl includ effect gener price supplier
price power claim volum pbm oper
effect potenti aetna acquisit addit
factor effect consum discretionari spend
upon retail oper bull case factor
less price profit pressur due regulatori
headwind assum abl exert even
negoti leverag supplier tri contend
grow competit correspondingli factor
high-single-digit claim volum growth firm abl
increas client base beyond base assumpt
client steer benefit spend toward pharmaci
benefit retail oper assum economi
grow materi greater rate recent
drive sale high singl digit final
factor near flawless integr aetna
asset drive value-cr versu value-destruct
scenario fair valu estim increas
bear case assum consolid among
leverag player
addit assum govern regul pressur
price profit greater degre anticip
base case firm retail oper also suffer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
analysi point signific opportun
cvs/aetna improv profit return outlook
busi success drive insur
member lower-cost company-own facil
offset posit tailwind increas
cost firm retail oper given asset
reformul healthcar two
factor lead us rate new combin firm narrow
believ new busi model develop
cvs/aetna merger drive signific level
econom valu strong narrow moat
perspect complex busi high
level execut need integr could pose
somewhat issu certain aspect merger
fumbl addit creation new busi model
also carri materi level uncertainti
implement new strategi evolv
time give us paus regard long-term
return capit -- prevent us award new
conglomer wide moat nonetheless believ
like new cvs/aetna churn materi
econom profit extend period formul
recent announc seek acquir aetna
move vertic expand oper health
insur success close deal
execut ambiti strategi would transform
one power player within
healthcar space analyz oper merit
combin entiti believ new cvs/aetna
possess narrow moat posit moat trend
drive posit trend believ steadili
greatli scenario assum growth
neg territori fair valu estim decreas
assumpt
believ merger cvs/aetna premier
healthcar servic player possess narrow
opportun take advantag two key industri
driver supplier price leverag central cost scale
total adjust claim approxim billion
pbm abl negoti top-tier drug price discount
supplier factor give advantag expand
client base preserv gross margin scale
also sourc competit advantag addit
claim process profit previou
aetna acquisit extend
vertic integr within healthcar space new
firm fundament chang healthcar
provid individu view transact
posit oper standpoint believ new
entiti one power player within
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
competit advantag grow stronger
strengthen competit advantag
new
cvs/aetna roll healthcar hub strategi heart
new combin narrow moat firm
abil control almost everi aspect healthcar
treatment member key piec strategi
retail locat new entiti plan use
healthcar hub allow member
obtain plethora healthcare-rel servic addit
current pharmaci retail product current
sold locat gather
servic includ
plan sale expert within hub guid
potenti member determin right insur plan
need
treatment plan consult assist
member determin right cours treatment
health cost perspect
medic product distribut member -- drive
much care home set possibl
treatment member minuteclin exam
diagnost test check-up limit procedur
believ newli develop healthcar hub give
cvs/aetna abil move signific amount
member treatment servic good procedur
costlier hospit physician offic set dynam
ultim allow firm treat member lower
cost basi aetna could stand-alone insur
firm find foot new strategi
member current new becom comfort
new healthcar treatment deliveri model expect
return capit continu increas firm
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ocv one largest pbm premier
healthcar servic player process approxim
billion adjust claim give firm
top-tier supplier negoti power scale
opharmaceut spend grow robust rate
next sever year given demograph shift
expans medic insur coverag
current uninsur
owe believ potenti acquisit aetna
make one power player within
entir economi
headwind pbm price pressur increas
oif supplier success control
product consolid could lose
price power
owe believ overpay aetna base upon
stand-alone valuat manag care player
dynam requir near flawless merger
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
solid financi health given current oper
free cash flow firm healthcare-rel oper
provid solid foundat long-term financi stabil
howev plan issu signific amount new
debt order acquir aetna firm state like
increas long-term debt approxim billion
push
debt/ebitda ratio time
manag state seek lower debt level
move debt/ebitda level back current level
time given robust cash flow produc
new cvs/aetna entiti believ goal reason
face oper risk push greater
regul pharmaceut industri player consum
discretionari spend consolid among
supplier partner concert push
certain pharmaceut player creat price
transpar govern could enact price cap
pbm acquisit cost becom greater result could
hurt return firm revenu also materi tie
sale nonpharmaceut product retail
locat product tie consum discretionari
spend downturn economi would
supplier could pose risk player success
maintain price power built
firm also face greater amount systemat risk
major rival signific portion revenu profit
tie consum discretionari spend addit
current oper concern believ potenti risk
poorli execut merger integr aetna
materi firm highli complex entiti
command signific portion market share within
respect sub-market price paid acquir aetna
requir near flawless integr effort
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
tough task given previous mention dynam
firm
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
believ stewardship larg fair
sharehold manag strategi shift firm
toward all-encompass healthcar player
prudent move strategi posit firm
advantag long term cost effici
servic critic healthcar sector
manag also made value-cr
acquisit purchas retail
pharmaci move allow firm expand retail
footprint instantli without major roll-out new store
howev cautiou regard price plan
pay aetna acquisit believ firm
overpay asset requir highli optim
integr oper given larg size
complex natur firm tough task
believ threat sharehold valu destruct
result materi
repres date owner name posit common share held report holder issuer
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
despit amazon acquisit pillpack market
june amazon announc purchas mail-ord
pharmaci start-up pillpack move give amazon
foothold within pharmaceut suppli chain
logic step on-line conglomer make
believ retail pharmaci go easiest
segment pharmaceut suppli chain amazon
enter howev also believ still tough
firm creat major disrupt within healthcar
space given insur dynam drive market
perspect new competitor need deal
larg power custom despit
market particip believ true end custom
pharmaceut space consum drug
rather insurer/employer/govern pay
health benefit consum accordingli expertis
need profit navig space preclud easi
opportun new entrant believ current
downward stock price move fear new disrupt
competit drug space creat opportun
investor acquir solid moati firm drug wholesal
pbm industri discount
perspect three key variabl
overlook market particip
stakehold analyz potenti new meaning
competit within pharmaceut market
true custom along chain busi
provid health benefit consum provid
health benefit make almost decis regard drug
pharmaci access busi also sourc suppli
drug partnership togeth b-to-b market
develop use drug health insur
base treat medic ailment consum demand
cash pay market estim less
prescript paid consum directli cash-
pay basi without insur dynam would take
mani consumer-bas compani built
core-compet get involv
pharmaceut space
price pharmaceut
drug price high-profil issu engulf
pharmaceut space percept new
entrant particular amazon instantli enter space
cut price drug product howev actual
price drug alreadi low given massiv amount
buy power pbm drug wholesal retail
pharmaci accumul new entrant would hold
minuscul amount purchas power compar
massiv joint sourc ventur
develop last hand year thu level
gener drug discount brand drug rebat new
entrant could command would pale comparison
major pharma supply-chain player make difficult
price competit
access global suppli drug requir
viabl player within pbm pharma wholes
retail pharmaci space access everi legitim drug
requir due variabl demand health
insur product viabl pharma player need abl
access plethora drug
manufactur across world level access
achiev major drug market servic player
new entrant reach level
option clear major drug benefit provid
seller purchas pharmaceut
detail analysi competit dynam
pharmaceut space amazon podeti disrupt
pleas see report sell drug easier said done
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
moati pharma channel
report solid aetna acquisit continu
report strong first quarter reiter
fair valu estim wide-moat pharmaci
benefit manag firm report robust increas
revenu segment effort becom prefer
pharmaci restrict network drove retail top line
good gain client win client member growth
bolster pbm oper impress also
expand gross oper margin basi
retail segment
experi decreas gross margin
forc discount gener pharmaceut product
order obtain prefer pharmaci statu sever pbm
pharmaci network howev firm abl off-set
headwind reduct central
cost drive overal oper margin segment
basi point believ manag great job
drive profit recov top line quarter
main focu investor move forward
acquisit aetna
manag said merger track expect
close end establish integr
team realign oper make transit easier
issu acquisition-rel bond lock low cost
debt aetna report also reorgan
oper combin healthcar oper
sell nonhealthcar busi addit
medicar member look build portfolio one
fastest-grow consist health insur
cohort develop fall line
manag team aetna said
state oper goal new healthcar servic
compani believ prepar well ahead
transact close posit lessen
major integr issu two complex firm
manag also provid color relat vision
new cvs-aetna healthcar entiti see two major
strateg pillar combin manag team tri
acquir high-mainten higher-cost member
opportun servic effici
cost-effect
drive much healthcar servic consumpt
non-acute-car facil particular retail locat
member home-car set
believ overal strategi signific potenti
drive materi econom profit come decad
combin new cvs-aetna healthcar
servic firm fundament chang healthcar
provid individu view transact
posit oper standpoint believ new
entiti one power player
healthcar ecosystem ultim view new cvs-
aetna entiti healthcar servic behemoth
infrastructur sell insur manage/treat member
everi aspect healthcar treatment
perspect capabl key asset
servic member chronic recur medic
issu firm abl leverag signific
retail footprint power pbm better control
cost treat patient firm also abl
underwrit plan design capabl sale
market expertis believ combin
oper give new cvs-aetna entiti key
advantag bring cost treat tradit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
report decent quarter lay groundwork
recent announc seek acquir
major managed-car firm aetna health taken
anoth step toward becom all-encompass
healthcar servic conglomer compani build
oper toward goal expect
mix result realign busi model fourth-
quarter result reflect trend report decent
top-lin growth gross profit expans howev
oper margin compress compani make
invest infrastructur balanc believ
make correct long-term strateg move given
secular trend blow entir healthcar
market reiter wide moat rate
fair valu estim combin dynam
under-valued stock make excel opportun
investor seek high-qual healthcar player
signific discount opinion
said solid pharmaci benefit manag
sell season report billion net new busi
client retent rate find
develop highli posit think trend point
valu larg pbm peer bring payer
client gross margin gross profit per claim
expand good clip increas basi point
respect howev
oper expens increas pressur profit
firm made invest prepar transit
contract also believ lower profit
driven onboard new busi new pbm
client usual yield lower level profit
first year manag say streamlin
pbm segment expect divis run
effici invest wind
would like see resumpt profit expans per claim
come quarter expect case
given scale advantag inher pbm busi
increas total claim volum
news lot posit retail pharmaci
segment quarter overal revenu remain flat
oper margin expand impress basi
point manag said sought ration
promot program robust cold flu season
drove posit result howev foot traffic same-stor
sale remain tepid firm still feel neg
effect exclud sever restrict pbm retail
pharmaci network believ neg volum trend
revers come year partner
mani peer move back sever restrict
pbm network pure-play retail segment
continu less driver firm oper
manag continu transform healthcar
servic specialist howev retail asset
drag result past sever quarter
believ play integr role firm look
leverag evolv services-focus busi
major updat relat propos
acquisit aetna manag say expect
deal close end deal progress
request depart justic inform
relat merger perspect new cvs-
aetna healthcar servic firm fundament chang
healthcar provid individu view
transact posit oper standpoint
believ new entiti one power
player healthcar ecosystem ultim view
new cvs-aetna entiti healthcar servic behemoth
infrastructur sell insur manag
treat member everi aspect healthcar
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
treatment regimen nevertheless concern
significantli overpaid aetna believ
per share price rich compar stand-
alon fair valu estim health insur
perspect potenti run risk materi
sharehold valu destruct deal execut
optim unabl drive synergi beyond cost
disrupt pbm mco wholesal jan
amazon berkshir hathaway jpmorgan
announc jan trio form independ
healthcar compani help control healthcar cost
 -base employe could
potenti given capit clout three partner
believ certain investor underappreci
moati natur healthcar suppli chain
formid competit advantag insul
signific headwind tri break vertic along
chain dynam healthcar market
difficult navig specul amazon
berkshir jp disrupt space leverag
impress capit war chest busi expertis
caus valuat pbm mco drug wholesal
retail pharmaci fall materi believ
stock price creat
opportun investor acquir solid wide-moat firm
discount would highlight express script
cardin particularli good
exact oper structur products/servic
ultim mandat partnership yet
develop partnership tri
sizabl corpor busi without major
chang within healthcar marketplac capit
manag clout three partner undoubtedli
great howev core-compet healthcar
relat take signific time legitim
oper develop addit believ potenti
new partnership would lack scale size provid
effici price power par major
healthcar servic firm especi case given
local densiti necessari obtain decent provid price
sourc joint ventur among retail pharmaci
drug distributor pharmaci benefit manag
combin number employe firm
close million initi may seem like give
partnership signific price power howev even
firm abl leverag entir million-person
employe base would pale comparison larg
healthcar servic firm equival small/mid-
tier insur estim combin number cover
live five major mco approxim
million live three larg pbm million
live respect thu price power new
partnership would garner significantli lower
healthcar servic firm built addit
mani employe trio base intern
hous independ oper like bring
total number one million potenti cover live
regul legal requir need effici
deliv healthcar extrem oner
absolut need consum safeti
would new entrant need compli variou feder
agenc claim regulatori jurisdict healthcar
servic product also countless state
municip foreign agenc licens regulatori
approv would take year new partnership fulli
compliant abl provid full-servic healthcar
servic employe administr work
wait period would also add signific time
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
regulatori approv process perspect amazon
berkshir jp new entrant healthcar
market would need partner one three larg
pbm one five larg mco order viabl
player within space
overview drug suppli chain would highlight
recent report sell drug easier said done
moati pharma channel analyz potenti
new competit within pharmaceut market
analysi wide moat exist space
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
